Popular Articles

Health Secretary Says New Mexico Must Address Serious Obesity Problem
In response to Trust for America"s Health "F as in Fat" report released today, Health Secretary Alfredo Vigil, MD, said New Mexico needs to continue to strengthen its obesity-prevention efforts to address a serious problem with obesity. The report details obesity rates by states and discusses effective state policies and programs.
drugs without prescription
APIC Supports Automated Surveillance Technologies In Prevention Of Healthcare-Associated Infections
In response to the need for expanded monitoring and reporting of healthcare-associated infections (HAIs), the Association for Professionals in Infection Control and Epidemiology (APIC) today announced its support for the use of automated surveillance technologies in the healthcare setting as an essential part of infection prevention and control activities. The recommendations are published in the APIC position paper, "The Importance of Surveillance Technologies in the Prevention of Healthcare-Associated Infections (HAIs)."
News of the day
CCA, AIMp And NPA Statement: Decriminalisation Of Dispensing Errors
The decriminalisation of dispensing errors is an issue that has united the profession.
Health Insurance

Online Reporting System For Swine Flu Antiviral Side Effects

Suspected side effects to swine flu antiviral medicines can now be reported to the Medicines and Healthcare products Regulatory Agency (MHRA) via a new dedicated webpage (http://www.mhra.gov.uk/swineflu). The online system is based on the highly successful Yellow Card Scheme and is designed to make completing a report quick and easy for the public as well as healthcare professionals. This will assist the MHRA in efficiently monitoring the safety of the swine flu antiviral medicines, Tamiflu and Relenza, as their use increases during the swine flu pandemic. MHRA Director of Vigilance and Risk Management of Medicines, Dr June Raine, said Tamiflu and Relenza are acceptably safe and most people will not suffer any side effects. "Like all medicines, the MHRA keeps the safety of these continually under review and we are keen to let people know there is a new way to tell us of any side effect suspicions. "If someone thinks they may have had a side effect to their medication, they should see their healthcare professional first to check they are okay. They should then report it to the MHRA via the "Swine Flu ADR Portal". "If they are unable to access the Internet, their healthcare provider can send a report on their behalf. "By providing this information, not only are the MHRA able to gain better insights into the safety of medicines, but people can directly contribute to effective medicines regulation." Notes 1. The UK has stockpiled the antiviral medicines Tamiflu and Relenza for management of the swine flu pandemic. 2. The existing Yellow Card Scheme will remain in operation during this time for reporting suspected ADRs to all other medicines. 3. The MHRA has received 20 suspected ADR reports to Tamiflu and no suspected ADR reports to Relenza since the start of the swine flu outbreak. No new risks have been identified. MHRA


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):